PROCARE B20 Patient Monitor, V1; and B20 Patient Monitor, V2. The PROCARE Monitor B20 is a portable multiparameter unit to be used for monitoring and recording of, and to generate alarms for, multiple physiological parameters of adult, pediatric, and neonatal patients in a hospital environment and during intrahospital transport.
Published December 19, 2018 · Recall initiated: September 11, 2018
Summary
FDA records medical device Class II recall Z-0583-2019, published December 19, 2018 and initiated September 11, 2018. Recalling firm: GE Healthcare, LLC; Status: Ongoing; Reported quantity: 28,004 patient monitors; Lot: All monitors. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Patient monitors may restart due to network overload caused by network configuration.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- GE Healthcare, LLC
- Distributor
- Worldwide Distribution: US (nationwide) including Puerto Rico; and countries of: Algeria, Argentina, Australia, Austria, Azerbaijan, Bahamas, Bangladesh, Belgium, Bolivia, Bosnia-Herzegovina, Brazil, Brunei, Bulgaria, Burma (Myanmar), Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Ethiopia, Finland, France, Gabon, Georgia, Germany, Greece, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Ivory Coast, Jamaica, Jordan, Kampuchea, Kazakstan, Kenya, Korea, Kuwait, Lebanon, Lithuania, Macedonia, Malaysia, Mexico, Moldova, Morocco, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Senegal, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Tunisia, Turkey, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela, Viet Nam, and Zambia.
- Lot
- All monitors
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACentricity PACS Software Version 7.0 SP0.0.4.7August 3, 2022
- FDASIGNA Premier magnetic resonance scanner, model 5748519.July 27, 2022
- FDAGE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images andJuly 13, 2022
- FDABack up batteries in Avance CS2 and Avance CS2 Pro anesthesia devices manufactured on or after April 1, 2019July 6, 2022
- FDALaser Fiber Assy-Single Use-LFS-200-0.22NA-SMA905-Extension Sleeve Silver-Sterile ETO-ForTec FiberDecember 19, 2018
- FDAOrthopedic Salvage System (OSS) Porous Stem, Item No. 150394December 19, 2018
Questions about this recall
Was PROCARE B20 Patient Monitor, V1; and B20 Patient Monitor, V2. The PROCARE Monitor B20 is a portable multiparameter unit to be used for monitoring and recording of, and to generate alarms for, multiple physiological parameters of adult, pediatric, and neonatal patients in a hospital environment and during intrahospital transport. recalled?
Yes. FDA published recall Z-0583-2019 on December 19, 2018. Reported hazard: Patient monitors may restart due to network overload caused by network configuration.
What should I do if I have this product?
Voluntary: Firm initiated · Letter